Navigation Links
Damon Runyon Cancer Research Foundation awards prestigious fellowships to 17 top young scientists
Date:6/19/2009

y critical roles in neuronal development and diseases, such as brain tumors (astrocytomas). Understanding how astrocytes are generated and maintained in the brain will help to develop better strategies for treating astrocytomas.

Nadya Dimitrova, PhD, with her sponsor Tyler Jacks, PhD, at the Massachusetts Institute of Technology, Cambridge, Massachusetts, is studying the role of a novel class of RNA molecules, lincRNAs, in tumor suppression. By dissecting the mechanism by which lincRNAs influence tumor suppressor pathways, she hopes to identify new markers for cancer diagnosis as well as novel approaches for effective cancer treatment.

Chuan-Hsiang Huang, MD, PhD [Harold L. Plotnick Fellow] with his sponsor Peter N. Devreotes, PhD, at The Johns Hopkins University, Baltimore, Maryland, is studying chemotaxis, a process by which cells migrate in response to naturally-occurring chemical cues in the human body. This process is essential for normal cellular movements as well as for the spread of cancer cells (metastasis). Better understanding of chemotaxis will facilitate the development of strategies to block cancer metastasis.

Daniel H. Kim, PhD, with his sponsor Jeannie T. Lee, MD, PhD, at Massachusetts General Hospital, Boston, Massachusetts, is studying how noncoding RNAs (unique RNAs that do not make proteins) control gene expression during a developmental process in females called X-inactivation, which turns off all genes on an entire chromosome. His work may provide insights into novel regulatory roles for noncoding RNAs in silencing tumor suppressor genes, while potentially revealing new therapeutic targets for the treatment of many types of cancer.

Liana F. Lareau, PhD [HHMI Fellow] with her sponsor Patrick O. Brown, MD, PhD, at Stanford University, Stanford, California, is investigating how the cell regulates translation, the process that turns the information in our genes into proteins. Misregulation of protein prod
'/>"/>

Contact: Yung S. Lie, Ph.D.
yung.lie@damonrunyon.org
212-455-0521
Damon Runyon Cancer Research Foundation
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. NYC Benefit Raises $1.4m for the Damon Runyon Cancer Research Foundation, Honors Merck
2. Reminder: Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium
3. Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium
4. The 2009 Damon Runyon-Rachleff Innovation Award Granted for Pioneering Ideas for Early Detection of Ovarian and Lung Cancers, Bone Marrow Transplant Safety, and Discovery of New Genetic Markers for Cancer
5. Damon Runyon Cancer Research Foundation awards $2.25M to 5 top young clinical investigators
6. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 14 top young investigators
7. Damons Grill Completes Move to Trans Fat-Free Menu
8. Mayo researchers: Dramatic outcomes in prostate cancer study
9. Moores UCSD Cancer Center Luau and Longboard Invitational Announce Dr. David Easter to Receive the 2009 Rell Sunn Queen of Makaha Award
10. Oncology Care Quality Improvement Program Introduced by Bipartisan Coalition Dedicated to Better Cancer Care Nationwide
11. Green Tea Component May Slow Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... China,s leading high-tech,healthcare group, Golden Meditech Company Limited ... pleased to announce today that the Group,s,associate company ... China Holdings Limited, made its debut on the ... secondary offering. The shares of FunTalk started,trading on ... As of today, Golden Meditech ...
(Date:12/17/2009)... Data from a recent Thomson Reuters study show that ... papers in 1998 to nearly 112,000 in 2008. ... 2% of the biomedical literature, has evaluated more than ... While only 27 Chinese-authored papers were selected in 2004, ... set to be even higher in 2009. , Jane ...
(Date:12/17/2009)... hospital clients Rutherford Hospital Inc. (Rutherfordton, N.C.), a management ... management client since 1992, were recently recognized as top-ranked ... ... Brentwood, Tenn. (PRWEB) ... Rutherford Hospital Inc. (Rutherfordton, N.C.), a management client since ...
(Date:12/17/2009)... Discuss Business Strategies, Solutions, and Scientific Studies Important ,for the ... ... MA (PRWEB) December 17, 2009 -- Cambridge Healthtech Institute is ... companies at its 2nd Annual Adopting R&D Informatics Systems conference ... North Convention Center in San Francisco, CA. This meeting has ...
(Date:12/17/2009)... 17 Motionsoft, Inc. announced today that ... Industry (PCI) Data Security Standards (DSS) certification, making ... vendors in the health and wellness space that ... Standard is the result of a collaborative effort ... (Visa International, MasterCard Worldwide, American Express, Discover Financial ...
Breaking Medicine News(10 mins):Health News:Golden Meditech's Associate Company Debuted on NASDAQ 2Health News:China rapidly catching up in research impact 2Health News:QHR Client Hospitals in North Carolina, Michigan Lauded for Providing Community Value 2Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 2Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 3Health News:Motionsoft Completes PCI Compliance Certification 2
... that bulimia primarily affects privileged, white teenagers such as ... the show earlier this season. , Rather, girls ... than girls who are white to be bulimic, the ... income bracket studied are 153 percent more likely to ...
... a Long-Term Trend in Infant HealthWHITE PLAINS, N.Y., March 18 ... - a finding that the March of Dimes hopes will ... improved maternal and infant health. The preterm birth rate declined ... among babies born to African American and white women."We,re encouraged ...
... Innovative Electronic Patient Reported Outcomes (ePRO) Solutions and Patient Questionnaires for ... use their state-of-the-art smart phone technology to collect data from patients ... trial. , ... Scottsdale, AZ (PRWEB) March 18, 2009 ...
... (OTC Bulletin Board: NVLX), formerly eFoodSafety.com, Inc. (OTC Bulletin ... permanent tattoo ink designed to be safe and easier to ... shown on February 22, 2009 on PBS member station WSIU. ... ink as well as its use in creating permanent tattoos ...
... Suggests Parents Most Influence Teens, Decisions About SexWASHINGTON, March 18 ... 1% in 2007, according to data released today by the ... second year in a row that the teen birth rate ... decline in the teen birth rate. That is, after ...
... that the PSA test is a far from perfect tool ... offer conflicting views on the value of screening men with ... , But at least one leading oncologist says this much ... family history of prostate cancer should pay attention to a ...
Other Medicine News:Health News:Black girls are 50 percent more likely to be bulimic than white girls 2Health News:Black girls are 50 percent more likely to be bulimic than white girls 3Health News:Preterm Birth Rate Drops 2Health News:Preterm Birth Rate Drops 3Health News:Preterm Birth Rate Drops 4Health News:Smart Phones to be used by assisTek to Collect Patient-Reported Outcomes in a Large Multinational Clinical Trial 2Health News:Smart Phones to be used by assisTek to Collect Patient-Reported Outcomes in a Large Multinational Clinical Trial 3Health News:Nuvilex' Infinitink Tattoo Ink Featured on PBS alt.news 26:46 TV Program 2Health News:Teen Birth Rate Up For Second Year in a Row 2Health News:2 Studies Conflict Over Value of Prostate Cancer Screening 2Health News:2 Studies Conflict Over Value of Prostate Cancer Screening 3
(Date:12/16/2009)... Hospira, Inc. (NYSE: HSP ), ... today announced that it will host a conference call ... projections for 2010 on Thursday, Feb. 4, 2010, at ... its fourth-quarter and full-year 2009 results earlier that morning, ... call. ,, A live webcast of the conference call ...
(Date:12/16/2009)... Dec. 16 AVAX Technologies, Inc. (Pink ... that it recently closed a bridge loan financing ... and Warrant Purchase Agreement (the "Agreement") with Firebird ... Agreement, the Company sold a convertible promissory note, ... amount of US$1,400,000, and issued a warrant to ...
(Date:12/16/2009)... -- International, well-known,scientific experts were surprised ... mg/day),data presented as "extremely promising."[1] More ... clinicians critically reviewed these data.,These experts ... lipid-modifying,treatments, fenofibrate and bezafibrate, in treating ... patients with metabolic syndrome,and type 2 ...
Breaking Medicine Technology:AVAX Technologies, Inc. Closes Bridge Financing 2AVAX Technologies, Inc. Closes Bridge Financing 3AVAX Technologies, Inc. Closes Bridge Financing 4International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 2International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 3More Preemies Born Among the Poor 62390 1More Preemies Born Among the Poor 62390 2National HIV Non Profit Announces New Name 62386 1National HIV Non Profit Announces New Name 62386 2Mexico City to Build World Class Hub for Medical Research 62382 1Mexico City to Build World Class Hub for Medical Research 62382 2
... prospective, double-blind placebo controlled multi-center studies in patients with ... safety data in patients with focal dystonia and upper ... Academy of Neurology,s (AAN) 61st annual meeting in Seattle. ... plans to file a Biologic License Application (BLA) for ...
... Association Annual Meeting --SEATTLE and CHICAGO, April 28 ... DNDN ) today presented preclinical data demonstrating the ... which targets TRPM8 (a transmembrane cation channel protein), ... demonstrated the ability to reduce BPH alone and ...
Other Medicine Technology:Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 2Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 3Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 4Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 5Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia 2Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia 3Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia 4
... 2000 Digoxin Assay is a ... use in the quantitative analysis ... or plasma. Kits are packaged ... Roche COBAS MIRA, COBAS MIRA ...
The Emit 2000 Digoxin Assay is a homogeneous enzyme immunoassay for use in the quantitative analysis of digoxin in human serum or plasma. Kits are conveniently packaged in Olympus Reagent Cartridges ...
Liquichek Rheumatoid Factor Control is a liquid trilevel control designed to monitor rheumatoid factor testing procedures, including nephelometric and latex agglutination methods....
... The Newmarket Laboratories RPR kits use ... of lipid antigens, which will combine ... or plasma. The particles are suspended ... eliminate non - specific reactions. Positive ...
Medicine Products: